Date
- Tuesday, 6 November 2012, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
This event focused on experience gained from clinical trials in patients with, or at risk of, thromboembolism, and to gather opinions on how non-clinical, and paediatric clinical studies should be conducted. Information on demographics, biology and treatments as well as on the relationship between paediatric and adult population subsets, and between different disease conditions was also discussed.